Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry.

Proteomics
Regine M SchoenherrAmanda G Paulovich

Abstract

Access to a wider range of quantitative protein assays would significantly impact the number and use of tissue markers in guiding disease treatment. Quantitative mass spectrometry-based peptide and protein assays, such as immuno-SRM assays, have seen tremendous growth in recent years in application to protein quantification in biological fluids such as plasma or urine. Here, we extend the capability of the technique by demonstrating the application of a multiplexed immuno-SRM assay for quantification of estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) levels in cell line lysates and human surgical specimens. The performance of the assay was characterized using peptide response curves, with linear ranges covering approximately four orders of magnitude and limits of detection in the low fmol/mg lysate range. Reproducibility was acceptable with median coefficients of variation of approximately 10%. We applied the assay to measurements of ER and HER2 in well-characterized cell line lysates with good discernment based on ER/HER2 status. Finally, the proteins were measured in surgically resected breast cancers, and the results showed good correlation with ER/HER2 status determined by clinical assays. This is...Continue Reading

References

May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M HarveyD C Allred
Jun 6, 2002·Journal of the National Cancer Institute·Soonmyung PaikNorman Wolmark
May 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Scott A GerberSteven P Gygi
Oct 10, 2003·The New England Journal of Medicine·John M Goldman, Junia V Melo
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzRobert J Mayer
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Dec 14, 2004·Nature Biotechnology·John RushMichael J Comb
Dec 8, 2005·Molecular & Cellular Proteomics : MCP·Leigh Anderson, Christie L Hunter
Aug 11, 2006·Nature Biotechnology·Nickolas PapadopoulosBert Vogelstein
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lyndsay HarrisUNKNOWN American Society of Clinical Oncology
Jun 24, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Allen M Gown
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Georg SauerHelmut Deissler
Sep 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karin A Oien, T R Jeffry Evans
Oct 22, 2008·Applied Immunohistochemistry & Molecular Morphology : AIMM·Hadi YazijiUNKNOWN Members of the Standardization Ad-Hoc Consensus Committee
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guido SauterMichael F Press
May 5, 2009·Molecular & Cellular Proteomics : MCP·Michael A KuzykChristoph H Borchers
Jul 20, 2010·Analytical and Bioanalytical Chemistry·Nicole Schneiderhan-MarraThomas O Joos
Dec 1, 2007·Proteomics. Clinical Applications·Jian JiangChristoph H Borchers
Dec 8, 2010·Proteomics. Clinical Applications·Qin FuJennifer E Van Eyk
Jan 20, 2011·Molecular & Cellular Proteomics : MCP·Jeffrey R WhiteakerAmanda G Paulovich
Jun 21, 2011·Nature Biotechnology·Jeffrey R WhiteakerAmanda G Paulovich

❮ Previous
Next ❯

Citations

Jun 28, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ting YangYun Chen
Dec 22, 2012·Expert Review of Proteomics·Liping Chung, Robert C Baxter
Mar 23, 2013·Biochemistry·Daniel C Liebler, Lisa J Zimmerman
Jan 24, 2013·Proteomics. Clinical Applications·Kenneth D ColeLili Wang
Oct 16, 2015·Rapid Communications in Mass Spectrometry : RCM·Gergő KallóÉva Csősz
Jun 29, 2013·Biochimica Et Biophysica Acta·Andrew J PercyChristoph H Borchers
May 7, 2015·Journal of Proteome Research·Martin SjöströmEmma Niméus
Sep 26, 2013·Biochimica Et Biophysica Acta·Frederik WeißOliver Poetz
Nov 5, 2016·Expert Review of Proteomics·Mathilde GuerinLuc Camoin
Apr 21, 2021·Expert Review of Molecular Diagnostics·Rajesh AhirwarSaroj Kumar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.